Report cover image

In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry

Publisher Kalorama Information
Published Jul 01, 2024
Length 35 Pages
SKU # KLI18966046

Description

In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry


ISSUE In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry

(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
  • A comprehensive view of the IVD market with test categories covered and company briefs
  • M&A activities, selected partnerships & collaborations, partnership deals, and more
  • Industry & region watch to help tailor strategies
  • Analysis of news and events and reporting on news not easily available

Table of Contents

35 Pages
MARKET ANALYSIS: CLINICAL CHEMISTRY
OVERVIEW OF CLINICAL CHEMISTRY MARKET
MARKET OUTLOOK
Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ millions)
Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)
Major Product Activity
Lab-based Clinical Chemistry
Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ millions)
Point-of-Care Clinical Chemistry
Table: Market Summary: POC-based Clinical Chemistry Market, 2023 and 2028 ($ millions)
REGIONAL MARKET
Figure: Global Clinical Chemistry Sales Estimates and Projection, by Region, 2023 and 2028 ($ millions)
Table: Global Clinical Chemistry Sales Distribution, by Region, 2023 (%)
TOP COMPANY BRIEFS
Roche
Abbott
Danaher
EXECUTIVE NEWS BRIEFING
CUE HEALTH CALLS IT QUITS
ALLENZ HEALTH SECURES $60 MILLION IN FUNDING
NEXT GEN DIAGNOSTICS WELCOMES NEW SCIENTIFIC ADVISORY BOARD MEMBER
NEXT GEN DIAGNOSTICS OPENS FIRST U.S. LABORATORY
FINANCIAL HIGHLIGHTS: BIOMÉRIEUX & SEKISUI DIAGNOSTICS
Figure: bioMérieux Sales Distribution, by Business Segment, 2023 (%)
Table: bioMérieux Financial Review, by Business Segment, FY 2022 – FY 2-23 (€M)
Figure: bioMérieux FY 2022 vs FY 2023 Regional Sales Breakdown (€M)
Table: Sekisui Chemical Financial Results, FY 2022 and FY 2023 (Billions of Yen)
Table: Sekisui Chemical Annual Overview and Focus, FY 2023 and FY 2024 (Billions of Yen)
Table: Sekisui Chemical Net Sales, by Segment, FY22 and FY23 (Billions of Yen)
Figure: Sekisui Chemical Medical Division, Revenue Mix, by Type, by Quarter, Q1 FY22 - Q4FY23 (Millions of Yen)
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
MERGERS AND ACQUISITIONS
Table: Selected Diagnostic Market Mergers and Acquisitions Deals
PARTNERSHIPS AND COLLABORATIONS
INDUSTRY WATCH
COVID-19/FLU UPDATE
REGION WATCH
JAPAN
Figure: Japan National Health Expenditures, Year-on-Year Growth Rate, 1985-2019 (Yen trillion, %)
Figure: Japan: Changes in Number of Hospitals, by Hospital Type, 2015-2019
Figure: Japan: Changes in Number of Beds, by Bed Type and Number of Beds per Hospital, 2015-2019
Figure: Japan: Changes in Average Length of Stay, by Bed Type, 2015-2019
Figure: Japan IVD Market, by Segment, 2023 (%)
BROAD-BASED COMPANY ANNOUNCEMENTS
ANNOUNCEMENTS
QIAGEN Launches Gastrointestinal Molecular Panel in the United States
Illumina Spins Off Grail
QIAGEN Discontinues NeuMoDx System
DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay
Genetic Signatures Granted FDA Clearance for GI Kit

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us